For example, POLD1 is overexpressed in hepatocellular carcinoma and breast cancer, which predicts poor prognosis in patients, suggesting that POLD1 may be a potential prognostic marker and promising therapeutic target in cancers (5, 6). The gene discussed is POLD1; the disease is breast cancer.